Immunotherapy Combination Studies Need Rational Path Considering Patient Population - 102126

Spotlight
Video

Immunotherapy Combination Studies Need Rational Path Considering Patient Population

Loading........
Description: Lawrence Fong, MD of University of California, San Francisco explains how there are several combination therapies to study, but not enough patient-participants for these clinical trials. He hopes for a more rational path regarding patients in order to see which combination therapies will work. This was recorded at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.
Shared By : AnnualMeeting-SITC2017
Posted on : 03/06/17
Added : 2 years ago
Category : Immunotherapy